Cite
MLA Citation
Dazhi Liu et al.. “Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment.” Cancer medicine, vol. 11, 2022, pp. 1796–1804. http://access.bl.uk/ark:/81055/vdc_100153798125.0x000013